Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ThromboDx

ThromboDx
2012 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
4 FINANCING ROUNDS
Description

Provider of blood-based diagnostics services. The company operates as a molecular diagnostics company and uses platelet-powered platform for cancer diagnostics, infectious disease monitoring and prenatal testing.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Laboratory Services (Healthcare)
Parent Company
Primary Office
  • Linnaeusparkweg 10-2
  • 1098 Amsterdam
  • Netherlands

+31 06 00000000

ThromboDx Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore ThromboDx‘s full profile, request access.

Request full access to PitchBook

ThromboDx Executive Team (5)

Name Title Board
Seat
Contact
Info
Rolf Jan Rutten Chief Executive Officer & Co-Founder
Robert Al Chief Financial Officer & Co-Founder
Thomas Wurdinger Ph.D Chief Scientific Officer & Co-Founder
Jonas Nilsson Co-Founder
Bastiaan van der Baan Co-Founder